Psychopharmacology
A Master Class
2026
An advanced review for prescribing clinicians navigating
treatment-resistant psychiatric illness, complex pharmacotherapy, special populations and emerging therapeutics.
Clinical Decision-Making
Novel Therapeutics
Bipolar
Schizophrenia
PTSD
When first-line treatment is not enough, the clinical decisions become more complex.
This program connects psychiatric neurobiology with advanced treatment strategy across refractory illness,
bipolar disorder, schizophrenia, special populations and emerging therapeutic approaches.
From brain function to an individualized treatment strategy.
Four layers that shape modern psychiatric prescribing.
Advanced psychopharmacology across the conditions that challenge prescribing decisions.
The right treatment depends on the patient in front of you.
The program addresses populations in which psychopharmacologic decisions often require substantial adaptation.
Explore what is changing at the edge of psychiatric treatment.
What this course is designed to strengthen.
Understand the neurobiology of psychiatric disorders to inform targeted psychopharmacologic interventions.
Evaluate advanced strategies for refractory depression and complex bipolar disorder.
Assess emerging treatments including neuromodulation, psychedelics and Apps/AI in psychiatric care.
Tailor treatment strategies across pediatric, perinatal, geriatric and substance-use populations.
19 sessions across modern psychopharmacology.
2. Update on the Development of Antidepressant for Refractory Depression
3. Treatment of Bipolar Disorders: Rational Polypharmacy and Bipolar Depression
4. Psychopharmacology in Perinatal Mood and Anxiety Disorders
5. Psychopharmacologic Approaches in Childhood and Adolescents Affective Disorders
6. Panel Discussion 1
8. Psychopharmacology in Geriatrics and Neuropsychiatry Population
9. Therapeutic Approaches to the Difficult Patient: Difficult-to-Treat Depression
10. Panel Discussion 2
12. Neurobiology and Treatment of Sleep in Psychiatric Disorders
13. Apps and AI as Therapeutics
14. Mechanisms of Psychedelics and Their Potential Treatment for PTSD
15. Panel Discussion 3
17. Anxiety Mechanisms, Treatment of Anxiety Spectrum Disorders & New Benzodiazepine Data
18. The Status of Laboratory Testing to Predict Antidepressant Response: Problems and Promises
19. Panel Discussion 4
Built for clinicians making psychiatric prescribing decisions.
Everything included in the complete course.
Understand the mechanism.
Refine the treatment strategy.
Review advanced psychopharmacology across refractory illness, special populations and emerging psychiatric therapeutics.
Access the Complete 2026 Master Class →
Reviews
There are no reviews yet.